ClinicalTrials.gg
Sign In

Dengue clinical trials

The registry lists 283 studies for Dengue across more than 10 countries. 44 are recruiting or about to start. 215 of them are mainly about Dengue (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Severe Dengue too: 290 studies, 47 open.

Get an email when these change. Save the Dengue studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
176
Recruiting
27
Status unknown
26
Active, not recruiting
18
Not yet recruiting
14
Terminated
12

Phase

Phase 2
65
Phase 1
65
Phase 3
34
Early Phase 1
3
Phase 4
1

Where

United States
69
Thailand
30
Brazil
26
Colombia
21
Malaysia
20
Mexico
19

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (35) · Sanofi Pasteur, a Sanofi Company (30) · Takeda (17) · U.S. Army Medical Research and Development Command (16) · Sanofi (6) · Butantan Institute (6) · Mahidol University (6) · Oxford University Clinical Research Unit, Vietnam (5)

What is being tested here

Drugs under test in Dengue studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Carica papaya leaf112
Biological Products102
Montelukast122
Dexamethasone111
Acetylcysteine111
Baricitinib111
Molnupiravir101
Remdesivir101
Resomelagon101
Zanamivir101

Coming up

11phase 3 studies under way
16studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 27 Dengue studies recruiting now, 16 (59%) set no upper age limit and 11 (41%) stop at 75 or younger. 16 (59%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (33%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
1015 (56%)15 (56%)
1823 (85%)23 (85%)
3023 (85%)23 (85%)
4023 (85%)23 (85%)
5023 (85%)23 (85%)
6521 (78%)21 (78%)
7517 (63%)17 (63%)
8516 (59%)16 (59%)

Across all 283 studies, recruiting or not: 65% stop at 75 or younger and 62% at 65; 47% take children; 2% are for women only and 1% for men only; 67% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dengue studies take

Of 31 phase 2 interventional studies under Dengue, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo8–18 · 22 studies——
Phase 220 mo14–38 · 31 studies21 mo14–47 · 21 studies—
Phase 324 mo7–30 · 21 studies——
Interventional, no phase12 mo6–36 · 30 studies—12 mo5–27 · 25 studies
Observational47 mo31–71 · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 283. Browse all 283 → or search them.